Navigation Links
Dr. Malgorzata Borowiak returns to the MDC from Harvard
Date:9/29/2011

This press release is available in German.

Dr. Malgorzata Borowiak, a researcher in the Department of Stem Cell and Regenerative Biology at Harvard University in Cambridge, MA, USA, has been awarded a grant from the Helmholtz Association to return to the Max Delbrck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, as head of a Young Investigators Group. At the MDC, which is a member of the Helmholtz Association, Dr. Borowiak aims to contribute to diabetes research by studying the molecular basis of beta cell development. These cells, which produce insulin, a hormone essential for life, are defective in diabetics. Dr. Borowiak will also cooperate with Charit - Universittsmedizin Berlin.

Dr. Borowiak holds a Master's degree in Biotechnology from Adam Mickiewicz University in Poznań, Poland and completed her doctoral work under the supervision of Professor Carmen Birchmeier (MDC/Freie Universitt Berlin). She received her PhD degree in 2006 and then went to the U.S. for her postdoctoral work.

Altogether, this year the Helmholtz Association awarded Young Investigator grants to twenty early-stage researchers, ten of whom are women. They were selected from 226 applicants. With an annual budget of "at least 250, 000 euros over a period of five years and the prospect of gaining a tenure-track position", these grants, according to the Helmholtz Association, "are an ideal entry into a scientific career and are therefore attractive both for foreign applicants and for researchers who wish to return to Germany from a research stay abroad."

Half of the money will come from the Initiative and Networking Fund of the President of the Helmholtz Association and the other half from the research center at which the leader of the Young Investigators Group will work. Currently there are seven Helmholtz Young Investigators Groups at the MDC, including Dr. Borowiak's group.


'/>"/>

Contact: Barbara Bachtler
bachtler@mdc-berlin.de
49-309-406-3896
Helmholtz Association of German Research Centres
Source:Eurekalert

Related biology news :

1. Science returns to the Capitol Hill spotlight at March 24 exhibition
2. Science returns to Capitol Hill spotlight at April 14 exhibition
3. The LouseBuster returns
4. VIMS team returns to Antarctic Peninsula
5. Oldest known wild bird in US returns to Midway to raise chick
6. Research ship Polarstern returns from Antartica
7. Organizational Change Management for Sustainability: The Harvard Case Study
8. Harvard scientist says we are what we eat -- and what we cook
9. Duke, Harvard researchers to monitor bonobo reintroduction
10. Harvard scientists solve mystery about why HIV patients are more susceptible to TB infection
11. Harvard research team receives $10M NSF grant to develop small-scale mobile robotic devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2016)... BioDirection, a privately held medical device company ... detection of concussion and other traumatic brain injury (TBI), ... meeting with the U.S. Food and Drug Administration (FDA) ... During the meeting company representatives reviewed plans for clinical ... commencement of a planned pilot trial. ...
(Date:11/29/2016)... , November 29, 2016 Nearly one billion ... Continue Reading ... ... part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: The ...
(Date:11/24/2016)... 23, 2016 Cercacor today introduced Ember TM ... trainers non-invasively measure hemoglobin, Oxygen Content, Oxygen ... Respiration Rate in approximately 30 seconds. Smaller than a ... immediate access to key data about their bodies to ... regimen. Hemoglobin carries oxygen to muscles. ...
Breaking Biology News(10 mins):
(Date:12/6/2016)... ... December 06, 2016 , ... ... platforms, announced today that the company has engaged in a collaborative research partnership ... (MRDA) with the CSU Office of the Vice President for Research. This agreement ...
(Date:12/6/2016)... PARK, Calif. , Dec. 6, 2016 /PRNewswire/ ... up to $150 million from the National Institutes ... Diseases and the Division of AIDS (NIAID-DAIDS) to ... and other non-vaccine pre-exposure (PreP) agents. Under the ... of preclinical product development services for candidate HIV-prevention ...
(Date:12/5/2016)... ... 2016 , ... This composition patent, U.S. Patent No. 9,499,637, ... composition claims are not limited to any particular process to make or use ... fibers, graphene, and other materials. A continuation application, U.S. Patent App. No. ...
(Date:12/5/2016)... 2016  Renova™ Therapeutics, a biotechnology company developing ... other chronic diseases, announced that Catherine Bovenizer ... Financial Officer (CFO), effective today. Ms. ... experience in financial management for a variety of ... Most recently, Ms. Bovenizer was the Vice President ...
Breaking Biology Technology: